Mar 30, 2017 Last Updated 9:01 AM, Mar 30, 2017

University of Nairobi creates vaccination rewards card

ABN – A team from the University of Nairobi has won a US$120,000 share of the 2014 GSK and Save the Children Healthcare Innovation Award.

The teams bar-coded Vaccination/Mother and Child Wellness Card attracted the attention of the awards board as it tracks vaccinations and rewards mothers with discounts on farm products.

Many families in rural Kenya are unable to have their children and expectant mothers immunised due to the distance they live from the nearest health clinic, cost of the journey and the challenging vaccine fees.

The card tracks when a mother or child receives a vaccine and then allows the mother discounts on farm products from the University’s partner agency Agrovets.

Dr Benson Wamalwa, University of Nairobi spokesperson, said: "The vaccination card uses a unique model, never used anywhere else in the world, to address the challenges of under-vaccination and food security, so parents are no longer forced to choose between vaccinating their child and buying seed for the season's planting.

“Thanks to the card, children are vaccinated and protected against preventable illnesses for the rest of their lives and households enjoy better harvests which safeguard their nutrition and livelihoods."


UN Ebola chief calls for $1bn in funding

ABN – A UN Ebola chief has called for a final US$1 billion to fight West Africa’s epidemic of the disease as experts move to trace remaining cases.

David Nabarro, the doctor leading the UN’s fight against Ebola, estimated a total of $4 billion was needed by relief agencies and countries to end the epidemic.

The epidemic has already killed more than 8,400 people mainly in Liberia, Guinea and Sierra Leone.

UN bodies received two-thirds of its set target last year for the disease and Nabarro has now requested that the World Health Organization, UNICEF and the World Food Programme now need the same amount again.

Priority for the next few months will now lie in the tracing of all contacts of infected people.

Nabarro said: "I can't say how long it will take, but it is that last part of getting down to zero that might be the most difficult."


Julphar constructs medicine manufacturing facility in Ethiopia

ABN – Julphar will construct Africa’s largest injectable medicine producing facility in Ethiopia for around US$50 million.

An 11,000 square metre plot of land in Addis Ababa has already been acquired by the company to build the injectable medicine producing plants and warehouse facilities.

The plant will produce insulin for patients with diabetes across the African continent.

Julphar has also announced plans to carry out conferences and workshops to assist local pharmaceutical manufacturers.

Hassan Jibreel, Julphar senior director of corporate development, said: "We feel the local manufacturers really lack up-to-date knowledge in the area; so we want to focus on building up capacity through Good Manufacturing Practice and that is why we want to organise workshops to share our experience in that regard." 


This Month's Issue

ABN v4i2 web

Subscribe to our newsletter


Featured Companies Across The Network